<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0795">
 <label>159</label>
 <element-citation publication-type="journal" id="h0795">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Bai</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors</article-title>
  <source>Chem. Pharm. Bull. (Tokyo)</source>
  <volume>56</volume>
  <year>2008</year>
  <fpage>1400</fpage>
  <lpage>1405</lpage>
  <pub-id pub-id-type="doi">10.1248/cpb.56.1400</pub-id>
  <pub-id pub-id-type="pmid">18827378</pub-id>
 </element-citation>
</ref>
